Skip to content

Research paper

An 18-mo randomized, double-blind, placebo-controlled trial of DHA-rich fish oil to prevent age-related cognitive decline in cognitively normal older adults.

The American journal of clinical nutrition
Q1
May 2018
Citations: 52
Influential: 3
Interventional (Human) Studies
90

Study answer

What this study found

DHA-rich fish oil did not slow or improve cognitive performance over 18 months. The main cognitive findings were small negative effects on psychomotor speed (treatment = -0.02; 95% CI: -0.04 to 0.00; P = 0.03; d = 0.24) and on simple and choice reaction time (treatment = -0.02; 95% CI: -0.03 to 0.01; P = 0.05; d = 0.20). Sex and APOE-ε4 carrier status moderated some outcomes, including greater decline in retrieval fluency in women and improvement in reasoning among APOE-ε4 carriers. Secondary findings included worse perceived cognitive mistakes (Cognitive Failures Questionnaire, d = 0.24; P…

Study & population
Randomized, double-blind, placebo-controlled trial in cognitively healthy, community-dwelling older adults in Adelaide, South Australia.
Intervention
Participants received oral DHA-rich fish oil capsules for 18 months, 4 capsules per day.
Key limitation
The trial was modest in size for subgroup analyses, and the sex and APOE-ε4 interactions should be considered exploratory.
View sourceOpen PDF

Original abstract

Background Fish oil trials in cognitively healthy older adults have yielded inconsistent results. Supplementation may differentially affect the domains that underpin cognitive performance, and effects may differ across sex or genotype. Objective The …